16 June 2017

Bittium and Coronaria co-operate to further develop medical remote diagnostic services

Bittium Medanalytics Oy, part of Bittium group, and Coronaria Hoitoketju’s subsidiary Coronaria Analyysipalvelut Oy, have today signed agreements according to which Bittium Medanalytics Oy sells its remote diagnostic service business to Coronaria Asiakaspalvelut Oy. According to the agreement Bittium supplies its web-based service used in monitoring cardiac abnormalities to Cornaria’s use. service is used by more than 70 Finnish health centers and private medical centers. The net sales of Bittium Medanalytics Ltd in 2016 was EUR 0.4 million.
Further, Bittium Technologies Ltd, part of Bittium group, has acquired 25 percent of the shares in Coronaria Analyysipalvelut Oy. Through this joint ownership Bittium and Coronaria aim at gaining synergies from Bittium’s device and system development and the interfaces formed by Coronaria’s clinical medicine and services.

“This co-operation agreement with Coronaria provides us with a large network of doctors and specialists to support our medical technology development. Bittium has over 30 years of experience in radio and biosignal measuring. We believe that through this cooperation we are able to improve the healthcare services by developing even more advanced systems and devices. Through this business transaction a significant amount of out-of-hospital biosignal measurements in Finland will use Bittium’s technology in the future” says Hannu Huttunen, CEO of Bittium Corporation.
Coronaria Analyysipalvelut Oy provides biosignal measurement and web-based remote diagnostic services in Finland and its customers are private medical centers, occupational healthcare doctors and hospitals. Coronaria provides approximately 25 000 diagnostic reports per year.

”Cooperation with Bittium is a significant step for Coronaria. We believe that by combining Bittium’s technology competence and Coronaria’s exceptionally wide industry knowhow we are together able to provide high-quality, easy-to-use and secure service solutions for our customers’ everyday life” says Ulla Näpänkangas, Managing Director of Coronaria Analyysipalvelut Oy.
The sale of the services business and share purchase agreement have no significant impact on Bittium Corporation’s operating result outlook for 2017 published in the Financial Statement Bulletin 2016 on February 20, 2017. The parties have agreed that the value of the transaction will not be published.

In its Medical Technologies product and services area Bittium provides among others Faros product family, focused on ECG recording and remote monitoring, NeurOne products focusing on measuring the electrical activity of the brain, and BrainStatus, a disposable quick EEG measuring headband used in emergency and intensive primary care to diagnose for example epileptic seizures and brain stroke, and other healthcare technology products. Bittium continues to develop these products further targeting to grow its product and service offering to healthcare and homecare markets.

No comments:

Post a Comment

CONTACTO · Aviso Legal · Política de Privacidad · Política de Cookies

Copyright © Noticia de Salud